Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma

Aim. Sal-like protein 4 (SALL4), is reexpressed in tissues of a subgroup of HCC associated with poor prognosis. Reports of SALL4 serological levels linked to HCC patients are meager and unclear in the prognosis of this malignancy. Methods. Immunohistochemistry and optical microscopy protocols were u...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Han, Su-xia, Wang, Jun-lan, Guo, Xi-jing, He, Chen-chen, Ying, Xia, Ma, Jin-lu, Zhang, Yuan-yuan, Zhao, Qian, Zhu, Qing
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4016881/
https://ncbi.nlm.nih.gov/pubmed/24860834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/262385
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados